Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Change in Accured Expenses (2016 - 2026)

Apyx Medical filings provide 15 years of Change in Accured Expenses readings, the most recent being $553000.0 for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 528.41% to $553000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $209000.0, a 109.22% increase, with the full-year FY2025 number at $209000.0, up 109.22% from a year prior.
  • Change in Accured Expenses hit $553000.0 in Q4 2025 for Apyx Medical, up from $79000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $1.8 million in Q3 2022 to a low of -$2.0 million in Q2 2023.
  • Median Change in Accured Expenses over the past 5 years was $79000.0 (2025), compared with a mean of $84947.4.
  • Biggest five-year swings in Change in Accured Expenses: soared 1046.85% in 2021 and later plummeted 5841.67% in 2022.
  • Apyx Medical's Change in Accured Expenses stood at $1.8 million in 2021, then increased by 1.12% to $1.8 million in 2022, then decreased by 21.09% to $1.4 million in 2023, then crashed by 93.84% to $88000.0 in 2024, then soared by 528.41% to $553000.0 in 2025.
  • The last three reported values for Change in Accured Expenses were $553000.0 (Q4 2025), $79000.0 (Q3 2025), and $433000.0 (Q2 2025) per Business Quant data.